-
-
-
-
-
-
-
Pfizer (PFE) and BioNTech (BNTX) Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
-
-
-
-
-
-
-
U.S. CDC advisers approve adding COVID shots to vaccine schedules
-
-
-
-
-
-
-
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
-
-
-
-
-
-
-
FDA Authorizes Moderna (MRNA) and Pfizer (PFE) -BioNTech (BNTX) COVID-19 Vaccines for Children Down to 6 Months of Age
-
-
-
-
-
-
-
CDC recommends Pfizer's COVID-19 booster for ages 12 to 15
-
-
-
-
-
-
-
FDA Authorizes Pfizer (PFE) -BioNTech (BNTX) COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
-
-
-
-
-
-
-
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine in Children 5 to <12 Years
-
15,653 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

